• SOTS 2nd Hour: The Black Friday Breakdown, plus Stocks & Streaming w/Al Michaels 11/29/24
    Nov 29 2024

    Carl Quintanilla, David Faber, and Sara Eisen talked the latest for stocks as the S&P hit another record high this shortened Black Friday holiday session. The team got a read from the ground at a local mall, discussed key winners and losers according to UBS, and broke down big trends with the CEO of L.L. Bean.

    Also in focus: a deep dive with legendary sportscaster Al Michaels, as he gives his predictions for across stocks, sports, and streaming.

    Squawk on the Street Disclaimer

    Show More Show Less
    42 mins
  • Bulls Rule in November, Black Friday Is Here, FTC vs. Microsoft 11/29/24
    Nov 29 2024

    On the last trading day of November, Carl Quintanilla, David Faber and Sara Eisen discussed the markets wrapping up a bullish month for stocks. Can the upward momentum continue into 2025? Veteran strategist Ed Yardeni joined the conversation. Black Friday also in the spotlight: A live report from a mall on the shopping action, how Apple and Amazon are positioned for the holidays, plus auto dealerships' push to lure car buyers. Also in focus: The FTC opens a broad antitrust probe into Microsoft, More reaction to President-elect Trump's tariff threats, why chip equipment makers are in rally mode.

    Squawk on the Street Disclaimer

    Show More Show Less
    42 mins
  • SOTS 2nd Hour: PCE Breakdown, Retail's "Big 5", and an Exclusive w/the CEO of American Express 11/27/24
    Nov 27 2024

    Carl Quintanilla, David Faber, and Sara Eisen discussed the latest for stocks ahead of retail's biggest 5 day stretch of the year: Thanksgiving to Cyber Monday. The Fed's preferred inflation gauge - PCE - came in as expected, with the team breaking down what it means for rates ahead. Also in focus: the state of small business with the Chairman & CEO of American Express.

    Squawk on the Street Disclaimer

    Show More Show Less
    47 mins
  • Inflation and the Fed, Trump's Tariff Threats and Economic Team Picks, A Downer for Dell 11/27/24
    Nov 27 2024

    One day after the Dow and S&P 500 hit fresh record highs, Carl Quintanilla, David Faber and Sara Eisen discussed a barrage of economic and inflation data ahead of the Fed's December decision on rates. The anchors also delved into President-elect Trump's tariff threats, as well as his choices to round out his White House economic team. A tough earnings picture for tech, led by Dell: Shares of the company tumbled on a revenue miss and light guidance. Also in focus: Softbank's investment in OpenAI, what American Express CEO Stephen Squeri told Sara about the economy, investing in weight-loss drug makers.

    Squawk on the Street Disclaimer

    Show More Show Less
    44 mins
  • Cramer's Morning Take: Amgen, Best Buy 11/26/24
    Nov 26 2024

    Cramer outlines how investors should navigate the next few days. Become a CNBC Investing Club member to go behind the scenes with Jim Cramer and Jeff Marks as they talk candidly about the market’s biggest headlines. Signup here: cnbc.com/morningtake

    CNBC Investing Club Disclaimer

    Show More Show Less
    4 mins
  • Squawk on the Street 2ND Hour 11/26/24
    Nov 26 2024

    The second hour of CNBC’s "Squawk on the Street" with Carl Quintanilla and Sara Eisen is broadcast each weekday from the floor of the New York Stock Exchange, with the up-to-the-minute news investors need to know and interviews with the most influential CEOs and greatest market minds.

    Squawk on the Street Disclaimer

    Show More Show Less
    44 mins
  • Trump's Tariff Threat, Retail Earnings Ahead of Black Friday, Amgen Tumbles on Weight-Loss Drug Data 11/26/24
    Nov 26 2024

    Carl Quintanilla, Jim Cramer and David Faber explored President-elect Trump's threat to impose tariffs on Mexico and Canada and raise them on China. What’s at stake for certain sectors in this market? With Black Friday just days away, the anchors discussed earnings and holiday quarter guidance from the likes of Best Buy and Dick's Sporting Goods. Also in focus: Shares of Amgen tumble after a mid-stage trial for its experimental obesity drug misses analyst expectations, President Biden proposes requiring Medicare and Medicaid to cover weight-loss drugs, bitcoin extends post-record slide, California Gov. Newsom vs. Elon Musk, Nvidia's new AI sound model.

    Squawk on the Street Disclaimer

    Show More Show Less
    42 mins
  • Cramer's Morning Take: Bristol Myers & Eli Lilly 11/25/24
    Nov 25 2024

    Jim and Jeff discuss why they’re buying this biopharmaceutical stock. They also talk about adding to this pharmaceutical stock. Become a CNBC Investing Club member to go behind the scenes with Jim Cramer and Jeff Marks as they talk candidly about the market’s biggest headlines. Signup here: cnbc.com/morningtake

    CNBC Investing Club Disclaimer

    Show More Show Less
    4 mins